Latest fiscal year 2026 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2026, PETMED EXPRESS, INC. reported revenue of $179M, down 21.1% year over year. Operating margin was -32.8% and net margin -32.0%, on a free-cash-flow margin of -18.4% with capital expenditure at 2.6% of revenue. Every figure is computed directly from PETS's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2026 | $179M | -32.8% | -32.0% |
| FY2025 | $227M | -0.7% | -2.8% |
| FY2024 | $274M | -3.0% | -2.7% |
| FY2023 | $248M | 2.4% | 2.1% |
| FY2022 | $272M | 8.9% | 6.9% |
How does PETS compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAP · ACI · AEO · AIXN · AKA · AMZN
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.